Dian Diagnostics Group Co Ltd
SZSE:300244
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
8.96
23.19
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Dian Diagnostics Group Co Ltd
Dian Diagnostics Group Co Ltd
Revenue
Dian Diagnostics Group Co Ltd
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Dian Diagnostics Group Co Ltd
SZSE:300244
|
Revenue
¥12.4B
|
CAGR 3-Years
0%
|
CAGR 5-Years
8%
|
CAGR 10-Years
26%
|
|
|
Guangzhou Kingmed Diagnostics Group Co Ltd
SSE:603882
|
Revenue
¥7.8B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
Topchoice Medical Co Inc
SSE:600763
|
Revenue
¥2.9B
|
CAGR 3-Years
1%
|
CAGR 5-Years
10%
|
CAGR 10-Years
18%
|
|
|
Nanjing Xinjiekou Department Store Co Ltd
SSE:600682
|
Revenue
¥6.7B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
7%
|
|
|
Meinian Onehealth Healthcare Holdings Co Ltd
SZSE:002044
|
Revenue
¥10.8B
|
CAGR 3-Years
5%
|
CAGR 5-Years
4%
|
CAGR 10-Years
25%
|
|
|
Jiangxi Rimag Group Co Ltd
HKEX:2522
|
Revenue
¥928.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Dian Diagnostics Group Co Ltd
Glance View
Nestled in the bustling city of Hangzhou, Dian Diagnostics Group Co Ltd has carved out a pivotal role in China's healthcare landscape. Established in 1996, the company's journey began with the humble yet crucial task of providing diagnostic services. Over the years, as the wave of technological innovation swept across the globe, Dian Diagnostics harnessed its potential to expand its service offerings, evolving into a comprehensive medical diagnostics powerhouse. The company operates through its expansive network of diagnostic laboratories, which leverage cutting-edge tools to deliver precise and timely results. This network serves hospitals, clinics, and other healthcare establishments, thus forming a vital link in the healthcare delivery chain. The heart of Dian Diagnostics' business model lies in its ability to integrate advanced technological solutions with healthcare needs, ensuring scalability and efficiency. The company's revenue streams primarily flow from the provision of diagnostic testing services and sales of diagnostic equipment and reagents. Owing to its commitment to innovation, Dian Diagnostics invests heavily in research and development, continuously enhancing its offerings in molecular diagnostics, pathology, and healthcare IT solutions. By catering to the ever-growing demand for reliable and rapid diagnostic services, the company sustains its growth momentum while contributing significantly to the advancement of healthcare quality in China.
See Also
What is Dian Diagnostics Group Co Ltd's Revenue?
Revenue
12.4B
CNY
Based on the financial report for Sep 30, 2024, Dian Diagnostics Group Co Ltd's Revenue amounts to 12.4B CNY.
What is Dian Diagnostics Group Co Ltd's Revenue growth rate?
Revenue CAGR 10Y
26%
Over the last year, the Revenue growth was -17%.
You don't have any saved screeners yet